Cephalometric craniofacial features of growing patients with chronic renal failure

Yousef Al-Thomali1, Tarek H El-Bialy

  • 1Dental School, Taif University, Saudi Arabia.

Archives of Oral Biology
|October 18, 2011
PubMed

Insights

Children with chronic renal failure (CRF) exhibit reduced craniofacial growth, particularly in posterior cranial base and facial heights. However, growth deficits in pediatric CRF patients may diminish with age, suggesting potential catch-up growth.

Area of Science:

  • Pediatric Nephrology
  • Craniofacial Morphology
  • Growth and Development

Background:

  • Chronic renal failure (CRF) significantly impacts physical growth in children.
  • Understanding craniofacial development is crucial for assessing overall health in pediatric CRF patients.

Purpose of the Study:

  • To investigate the craniofacial morphology of children with CRF using cephalometric analysis.
  • To compare the craniofacial structures of children with CRF to healthy controls.

Main Methods:

  • Cephalometric radiographs of 23 growing children with CRF (aged >5-16) and 23 controls were analyzed.
  • Data were categorized into three age groups and statistically analyzed using ANOVA.
  • Measurements included cranial base length, facial heights, gonial angle, and various facial plane angles.

Main Results:

  • Children with CRF showed significantly decreased posterior cranial base length across all age groups.
  • Posterior facial height was significantly reduced in younger CRF patients (groups 1 and 2).
  • Younger CRF patients exhibited altered facial angles and reduced anterior facial dimensions.

Conclusions:

  • Pediatric CRF is associated with impaired posterior craniofacial growth, especially in younger children.
  • Growth deficits appear less pronounced in older children with CRF, suggesting catch-up growth potential.
  • Craniofacial alterations in pediatric CRF may normalize with age.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...